Versuchen GOLD - Frei

Investors flag operating issues as Bira 91 eyes fresh capital

Business Standard

|

October 21, 2025

Investors of craft beer maker Bira 91 have raised concerns about capital burn rate and operating performance, even as the company looks to raise fresh rounds to augment growth and start production.

- AKSHARA SRIVASTAVA

Investors flag operating issues as Bira 91 eyes fresh capital

“There has been a promise to deliver, which has not been met in terms of operating performance and revenue scale. The company has been struggling with liquidity. It’s not just about name change, it had operating challenges — both in terms of working capital and managing business — across different states for a while,” an investor told Business Standard.

While the company has raised several rounds of capital, “the burn rate is also very high and without working capital, the engine cannot work. It has been struggling with capital for the last 12-18 months. But when one has pending liabilities, the capital also gets washed out quickly,” the investor added.

Meanwhile, another investor pointed out operating issues at the company, including a less-than-desirable length and breadth of distribution and an international foray “that in hindsight, was too early.”

According to data from Tracxn, institutional investors hold 28.6 per cent stake in the company. It is led by PeakXV, Sofina, Sixth Sense, MUFG and Tiger Pacific. Kirin Holdings holds another 20.3 percent.

In 2017, the craft beer maker had announced plans to start distribution in at least five international markets within two years of being founded.

WEITERE GESCHICHTEN VON Business Standard

Business Standard

Festival cheer, tax cuts fuelled strong CV recovery in Oct

India’s commercial vehicle (CV) market saw a strong festive recovery in October, with retail sales rising 177 per cent year-on-year (Yo-Y) to 107,841 units, according to the Federation of Automobile Dealers Associations (Fada).

time to read

1 mins

November 11, 2025

Business Standard

Pent-up demand boosted health insurance segment in October

Even as non-life insurers reported muted premium growth in October, standalone health insurers saw a robust 38 per cent year-on-year (Y-0-Y) surge.

time to read

2 mins

November 11, 2025

Business Standard

Bihar polls Phase-2: 37 mn voters set to decide fate of candidates

Tejashwi Yadav slams EC for not releasing genderwise voter data after Phase-1 of elections

time to read

2 mins

November 11, 2025

Business Standard

Lenskart lists flat after volatile debut; valuation debate lingers

Eyewear retailer Lenskart, whose rich valuation polarised investor opinion ahead of its initial public offering (IPO), made a choppy debut on the bourses on Monday, ending the day with marginal gains.

time to read

1 mins

November 11, 2025

Business Standard

Senate deal sets stage for end to US govt shutdown

Senators hope to skip past a series of steps that could drag voting all week

time to read

3 mins

November 11, 2025

Business Standard

Radisson Hotel Group plans to expand to 200+ unique locations in India

The Radisson Hotel Group plans to expand its footprint to more than 200 unique locations across India in the coming years, driven by rising demand from Tier-II and Tier-Ill cities, infrastructure growth, and multiple opportunities in leisure and religious travel markets.

time to read

1 mins

November 11, 2025

Business Standard

Business Standard

Fight climate crisis, not each other: UN climate chief to nations

UN Climate Change Executive Secretary Simon Stiell on Monday opened COP30 with a sharp warning that while the world has managed to bend the emissions curve downwards since the Paris Agreement, far stronger and faster action is needed to avert escalating climate disasters.

time to read

1 min

November 11, 2025

Business Standard

Joblessness slowed to 5.2% in Q2: PLFS data

Unemployment rate in rural areas fell to 4.4%

time to read

2 mins

November 11, 2025

Business Standard

Pharma units likely to face action for Schedule M violations

Micro, small and medium-sized pharmaceutical companies may face regulatory action for noncompliance with norms under the revised Schedule M, with the Central Drugs Standard Control Organisation (CDSCO) directing states to conduct inspections at drug manufacturing units, said industry experts.

time to read

1 mins

November 11, 2025

Business Standard

Business Standard

High alert after car blast near Red Fort

At least 8 killed and 24 injured; PM and Home Minister review the situation; Shah says ‘all angles open’

time to read

3 mins

November 11, 2025

Listen

Translate

Share

-
+

Change font size